These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 18232648)

  • 1. Generation of a set of simple, interpretable ADMET rules of thumb.
    Gleeson MP
    J Med Chem; 2008 Feb; 51(4):817-34. PubMed ID: 18232648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADMET rules of thumb II: A comparison of the effects of common substituents on a range of ADMET parameters.
    Gleeson P; Bravi G; Modi S; Lowe D
    Bioorg Med Chem; 2009 Aug; 17(16):5906-19. PubMed ID: 19632124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond size, ionization state, and lipophilicity: influence of molecular topology on absorption, distribution, metabolism, excretion, and toxicity for druglike compounds.
    Yang Y; Engkvist O; Llinàs A; Chen H
    J Med Chem; 2012 Apr; 55(8):3667-77. PubMed ID: 22443161
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building predictive ADMET models for early decisions in drug discovery.
    Penzotti JE; Landrum GA; Putta S
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):49-61. PubMed ID: 14982148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico modelling of ADMET-a minireview of work from 2000 to 2004.
    Norinder U
    SAR QSAR Environ Res; 2005; 16(1-2):1-11. PubMed ID: 15844440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of hERG inhibition of drug candidates using multivariate property and pharmacophore SAR.
    Johnson SR; Yue H; Conder ML; Shi H; Doweyko AM; Lloyd J; Levesque P
    Bioorg Med Chem; 2007 Sep; 15(18):6182-92. PubMed ID: 17596950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conference Report: update on ADMET.
    Dearden JC
    Future Med Chem; 2009 May; 1(2):249-51. PubMed ID: 21425967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater than the sum of its parts: combining models for useful ADMET prediction.
    O'Brien SE; de Groot MJ
    J Med Chem; 2005 Feb; 48(4):1287-91. PubMed ID: 15715500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ADME evaluation in drug discovery. 3. Modeling blood-brain barrier partitioning using simple molecular descriptors.
    Hou TJ; Xu XJ
    J Chem Inf Comput Sci; 2003; 43(6):2137-52. PubMed ID: 14632466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent uses of topological indices in the development of in silico ADMET models.
    Votano JR
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):32-7. PubMed ID: 15679169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming undesirable HERG potency of chemokine receptor antagonists using baseline lipophilicity relationships.
    Shamovsky I; Connolly S; David L; Ivanova S; Nordén B; Springthorpe B; Urbahns K
    J Med Chem; 2008 Mar; 51(5):1162-78. PubMed ID: 18257512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV; Sateesh K; Panchagnula R
    Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of calculated physicochemical properties of compounds on their ADMET profiles.
    Ma S; McGann M; Enyedy IJ
    Bioorg Med Chem Lett; 2021 Mar; 36():127825. PubMed ID: 33508464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive QSAR modeling for the successful predictions of the ADMET properties of candidate drug molecules.
    Khan MT; Sylte I
    Curr Drug Discov Technol; 2007 Oct; 4(3):141-9. PubMed ID: 17985997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The current limits in virtual screening and property prediction.
    Hutter MC
    Future Med Chem; 2018 Jul; 10(13):1623-1635. PubMed ID: 29953247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of predictive metabolism and toxicity modeling in drug discovery--a summary of some recent advancements.
    Wilson AG; White AC; Mueller RA
    Curr Opin Drug Discov Devel; 2003 Jan; 6(1):123-8. PubMed ID: 12613284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relating molecular properties and in vitro assay results to in vivo drug disposition and toxicity outcomes.
    Sutherland JJ; Raymond JW; Stevens JL; Baker TK; Watson DE
    J Med Chem; 2012 Jul; 55(14):6455-66. PubMed ID: 22716080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.